A DNA barcode for industrial strain tracing and its applications
By integrating artificially synthesized DNA barcodes into industrial strains and employing PCR amplification and sequencing technologies, the problem of tracing industrial strains in existing technologies has been solved, achieving proactive protection and accurate traceability, and is applicable to a variety of industrial microorganisms.
Patent Information
- Application Number
- CN202611616601.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-19
- Publication Date
- 2026-11-17
AI Technical Summary
Existing DNA barcoding technology is mainly used for species classification and strain identification, and has not yet been applied to the intellectual property protection and traceability of industrial strains, making it difficult to achieve proactive protection and accurate traceability of industrial strains.
Artificially synthesized DNA barcode sequences were designed and integrated into industrial strains. PCR amplification and sequencing were performed using specific amplification primers to achieve active protection and traceability of industrial strains.
It achieves proactive protection of industrial strains, provides unique molecular identification, supports parallel traceability management of multiple strains, and offers accurate and cost-effective detection. It is applicable to a variety of industrial microorganisms such as Corynebacterium glutamicum, Escherichia coli, and Bacillus subtilis.
Smart Images

Figure CN123108174A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the fields of microbial genetic engineering and industrial biotechnology, and in particular to a DNA barcode for tracing industrial strains and its applications. Background Technology
[0002] Corynebacterium glutamicum ( Corynebacterium glutamicum ), Escherichia coli ( Escherichia coli Bacillus subtilis ( Bacillus subtilis Industrial microorganisms, such as amino acids, organic acids, and enzyme preparations, serve as crucial platforms for the production of high-value-added products. With the rapid development of synthetic biology and metabolic engineering technologies, investment in the modification of industrial microorganisms is increasing, and the microorganisms themselves and the genetic modification technologies they carry have become core intellectual property rights for enterprises. However, as biological materials, microorganisms are easily replicated, difficult to trace, and easily spread, leading to increasingly prominent issues of microorganism theft and illegal use.
[0003] DNA barcoding technology has been widely used in the field of species and strain identification. Studies have shown that by screening for specific DNA sequences in a strain's genome, DNA barcodes can be designed to distinguish a target strain from other strains of the same species. These DNA barcodes can quickly and accurately identify specific strains from easily confused strains or other strains within the same species.
[0004] However, existing DNA barcoding technology is mainly used for species classification and strain identification. There is no technical solution to integrate artificially synthesized DNA barcodes as active protection elements into industrial strains, or to use them as "molecular ID cards" for intellectual property protection and traceability. Summary of the Invention
[0005] To address the aforementioned technical problems, this invention provides a DNA barcode for tracing industrial strains and its application. By integrating artificially synthesized non-natural DNA sequences as molecular identifiers into industrial strains, a technological leap is achieved from passive identification relying on natural genomic differences to active protection using exogenous tags. This artificially synthesized barcode is not limited by strain species and can be flexibly applied to various industrial microorganisms such as Corynebacterium glutamicum, Escherichia coli, and Bacillus subtilis.
[0006] In order to achieve the objective of this invention, the following technical solution is adopted: This invention provides a DNA barcode for tracing industrial strains, the nucleotide sequence of which is shown in SEQ ID NO.1.
[0007] CGTACGTCGATCGTACGTCGGACGTGCACGTACTGCGTACGTACGTCGACGTAGCATCGACGTACGTACTCGACGTGTACGTCGTAACGTCGACGTACGTCGTGCATCGACGTACGTCGA Furthermore, the DNA barcode has a nucleotide sequence length of 120 bp and a GC base pair content of 55%.
[0008] The present invention also provides a DNA barcoding system for tracing industrial strains, the barcoding system comprising: (1) The DNA barcode mentioned above; (2) Specific amplification primer pair, consisting of a forward primer and a reverse primer. The nucleotide sequence of the forward primer is shown in SEQ ID NO.2, and the nucleotide sequence of the reverse primer is shown in SEQ ID NO.3.
[0009] SEQ ID NO.2 5'-GCTAGCGTACGATCGATCGAT-3' SEQ ID NO.3 5'-TGCTACGATCGATCGCTAGTC-3' This invention also provides a method for constructing an industrial strain, comprising the following steps: S1. Synthesize the DNA barcode described above; S2. The DNA barcode sequence is cloned into the multiple cloning site of the shuttle expression plasmid to obtain the recombinant plasmid; S3. Transform the recombinant plasmid into the host bacteria; S4. Screen positive transformants to obtain engineered strains carrying the DNA barcode sequence.
[0010] This invention also provides a method for tracing the origin of industrial strains, comprising the following steps: S1. Extract DNA from the bacterial strain to be tested; S2. Using the DNA of the test strain as a template, perform PCR amplification using the forward and reverse primers as described in claim 3; S3. Sequencing the PCR amplification products; S4. Compare the sequencing results with the DNA barcode sequence.
[0011] The present invention also provides a recombinant plasmid comprising the above-described DNA barcode sequence.
[0012] The present invention also provides an engineered bacterium comprising the above-described DNA barcode sequence.
[0013] The present invention also provides the above-mentioned DNA barcode sequence, or a DNA barcode system for tracing industrial strains, or the application of industrial strain tracing methods in industrial strain tracing, identification, and intellectual property protection of industrial strains.
[0014] Furthermore, the industrial strain is selected from: Corynebacterium glutamicum ( Corynebacterium glutamicum ), Escherichia coli ( Escherichia coli ) or Bacillus subtilis ( Bacillus subtilis At least one of the following.
[0015] The present invention has the following technical effects: (1) Active protection, giving strains a molecular identity card: For the first time, artificially synthesized DNA barcodes are integrated into industrial strains as active protection elements, giving each engineered strain a unique molecular identity card. Existing DNA barcode technology only uses naturally occurring sequence differences in strains for passive identification, while this invention actively introduces DNA barcodes as anti-theft tags, realizing the transformation from passive identification to active protection.
[0016] (2) Flexible sequence combination enables parallel traceability of multiple strains: By designing barcodes composed of different sequences, different molecular ID cards can be assigned to different strains or different modified versions of the same enterprise, thereby realizing parallel traceability management of multiple strains.
[0017] (3) High specificity and strong evidentiary value: The present invention uses artificially synthesized non-natural DNA sequences, which have no known homologous sequences in public nucleic acid sequence databases. Its unique characteristics can be proved by BLAST alignment results (E value > 10, identity < 40%), and can be used as direct molecular evidence in related infringement cases.
[0018] (4) Genetic stability and accurate identification: The DNA barcode sequence described in this invention can still be stably detected after continuous passage of the strain. Experimental verification shows that the DNA barcode can still be accurately detected after 10 consecutive passages of the strain.
[0019] (5) Simple operation and low cost: The method of the present invention only requires PCR amplification and sequencing to complete the identification of strains, without the need for complex operations such as whole genome sequencing. It has the advantages of fast detection speed, low cost and strong universality. Attached Figure Description
[0020] To more clearly illustrate the specific embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.
[0021] Figure 1 BLASTN alignment results of DNA barcode sequences; Figure 2 : A flowchart of the continuous passage of Corynebacterium glutamicum anti-theft strains carrying DNA barcodes; Figure 3 Electrophoretic pattern of DNA barcode PCR detection results. Lane M is the DNA molecular weight standard, lanes 1-3 are positive transformants carrying DNA barcodes (amplified with a specific band of about 120 bp), and lane 4 is the control strain without barcodes (no amplified band). Detailed Implementation
[0022] To make the objectives, technical solutions, and advantages of this invention clearer, the technical solutions of this invention will be clearly and completely described below. Obviously, the described embodiments are only a part of the embodiments of this invention, and not all of them. Based on the embodiments of this invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this invention.
[0023] Example 1: Design of DNA barcode sequences 1. Design Principles The design of the DNA barcode sequences described herein follows these principles: (1) The sequence length is 100~500 bp, preferably 120~250 bp; (2) The GC content should be controlled between 40% and 60%; (3) Avoid forming hairpin structures or high GC regions, and avoid repeating sequences in the same direction; (4) It does not exist in nature and has no significant homology with known sequences in public nucleic acid sequence databases; (5) Avoid commonly used restriction enzyme sites during the design process to facilitate cloning operations; Restriction endonuclease sites are reserved at both ends of the sequence to facilitate integration into the expression plasmid.
[0024] 2. Sequence Design Results Based on the above principles, a DNA barcode sequence (SEQ ID NO.1) was designed and obtained, with a full length of 120 bp and a GC content of 55.0%, as follows: SEQ ID NO.1 (DNA barcode sequence, 120 bp) CGTACGTCGATCGTACGTCGGACGTGCACGTACTGCGTACGTACGTCGACGTAGCATCGACGTACGTACTCGACGTGTACGTCGTAACGTCGACGTACGTCGTGCATCGACGTACGTCGA 3. Uniqueness verification of DNA barcode sequences The DNA barcode sequence shown in SEQ ID NO.1 was compared with BLASTN in the NCBI GenBank public nucleic acid sequence database, with an E value threshold of 1×10⁻⁶. -5 The results showed that the sequence had no significant homology with any of the registered microbial genome sequences (E value > 10, identity < 40%), confirming that the sequence does not exist in nature and is only an artificially synthesized sequence, which can be used as a proprietary molecular marker for this strain.
[0025] Example 2: Design of DNA barcode-specific primers Specific PCR primers were designed for the DNA barcode sequence shown in SEQ ID NO.1, following the principles of primer design: (1) Primer length 18~25 bp; (2) GC content 40%~60%; (3) Annealing temperature 55~65℃, the difference in Tm value between upstream and downstream primers does not exceed 3℃; (4) Avoid the formation of primer dimers and hairpin structures.
[0026] The specific primer sequences obtained by design are as follows: Forward primer (SEQ ID NO.2): 5'-GCTAGCGTACGATCGATCGAT-3' (21 bp) Reverse primer (SEQ ID NO.3): 5'-TGCTACGATCGATCGCTAGTC-3' (21 bp) Example 3: Integration and Construction of DNA Barcoding System and Expression Plasmid 1. The plasmid backbone was selected using the *E. coli*-*Corynebacterium glutamate* shuttle plasmid pXMJ19. This plasmid carries the chloramphenicol resistance gene *cat* and the inducible promoter *tac*, and was synthesized by Nanjing Qingke Biotechnology Co., Ltd.
[0027] 2. Insertion of the DNA barcode sequence: The DNA barcode sequence shown in SEQ ID NO.1 designed in Example 1 was obtained through artificial synthesis. Restriction endonuclease sites (such as SacI and HindIII) were introduced at both ends of the sequence, and after enzyme digestion, it was cloned into the multiple cloning site of the pXMJ19 plasmid. Sequencing confirmed the correct insertion of the barcode sequence, and the recombinant plasmid pXMJ19-BC2 was obtained.
[0028] Example 4: Integration and Validation of DNA Barcoding System in Corynebacterium glutamicum 1. Strains and plasmids This embodiment uses Corynebacterium glutamicum (… Corynebacterium glutamicum ATCC 13032 was used as the starting strain, and the recombinant plasmid carrying the DNA barcode sequence constructed in Example 3 was used.
[0029] 2. Transformation The recombinant plasmid was electroporated into competent Corynebacterium glutamicum cells. Electroporation conditions: voltage 2.5 kV, resistance 200 Ω, capacitance 25 μF. After transformation, 1 mL of LBG medium was added, and the cells were heat-shocked at 46℃ for 6 min, followed by recovery culture at 30℃ for 2 h.
[0030] 3. Screening of transformants The transformed strains were plated on LB plates containing chloramphenicol (10 μg / mL) and incubated at 30°C for 48 h to screen for positive transformants.
[0031] 4. Integrated Validation (1) PCR verification: Plasmid DNA was extracted from positive transformants and PCR amplification was performed using primers shown in SEQ ID NO.2 and SEQ ID NO.3. PCR reaction conditions: 95℃ pre-denaturation for 5 min; 95℃ denaturation for 30 s, 56℃ annealing for 30 s, 72℃ extension for 30 s, for a total of 30 cycles; final extension at 72℃ for 5 min. Agarose gel electrophoresis showed that positive transformants could specifically amplify a DNA fragment of about 120 bp, while the control strain showed no amplification band.
[0032] (2) Sequencing verification: The PCR product was sequenced and the sequencing results were consistent with the sequence shown in SEQ ID NO.1, confirming that the DNA barcode had been successfully integrated.
[0033] Example 5: Verification of the genetic stability of DNA barcoding 1. Experimental Design The anti-theft strain of Corynebacterium glutamicum carrying DNA barcodes was continuously passaged in LB medium without selection pressure (without chloramphenicol) for a total of 10 generations. Samples were taken from each generation for preservation. Figure 2 2. Detection Methods Plasmid DNA was extracted from the strains of generation 0, generation 5, and generation 10, and PCR amplification and sequencing were performed using the primers shown in SEQ ID NO.2 and SEQ ID NO.3, as shown in Table 1.
[0034] Table 1: Results of DNA barcode genetic stability testing Note: "+" indicates positive amplification, and "-" indicates negative amplification.
[0035] As shown in Table 1, the DNA barcode sequence remained stable after 10 generations of passage in the strain carrying the barcode, indicating good genetic stability. The control strain failed to amplify the specific DNA band, indicating that the DNA barcode has high specificity. Figure 2 ).
[0036] Example 6: A method for tracing strains based on a DNA barcoding system 1. Traceability Process The standardized strain tracing process established in this invention is as follows: (1) Extract DNA from the test strain; (2) PCR amplification was performed using specific primer pairs (SEQ ID NO.2 and SEQ ID NO.3); (3) The amplification products were detected by agarose gel electrophoresis; (4) Sequencing analysis of positive amplification products; The sequencing results were compared with the DNA barcode sequence of the original strain.
[0037] 2. Source tracing criteria (1) If the test strain can amplify a specific DNA band and the sequencing result is consistent with the original sequence, it is determined that it is consistent with the source of the target strain; (2) If the test strain cannot amplify a specific DNA band or the sequencing results are inconsistent with the original sequence, it is determined to be of different origin.
[0038] The DNA barcoding system described in this invention can be applied to the following scenarios: (1) Protection of strain intellectual property rights: By integrating DNA barcodes as molecular identity cards into engineered strains, unique molecular markers are provided for patented strains held by enterprises. In patent infringement disputes, direct molecular evidence can be provided by detecting DNA barcodes.
[0039] (2) Parallel traceability management of multiple strains: For different strains of the same enterprise or different modified versions of the same strain, different barcodes are designed to form sequences to achieve parallel traceability management of multiple strains. For example, the barcode shown in SEQ ID NO: 1 can be used for the violacein production strain, and another sequence barcode can be used for the tryptophan production strain.
[0040] (3) Traceability and identification in commercial circulation of strains: In the process of commercial circulation of strains, DNA barcode detection can accurately determine the source of strains and prevent illegal replication and resale.
[0041] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, and not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features; and these modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the technical solutions of the embodiments of the present invention.
Claims
1. A DNA barcode for industrial strain provenance, characterized in that, The nucleotide sequence of the DNA barcode is shown as SEQ ID NO.
1.
2. DNA barcode for industrial strain provenance according to claim 1, characterized in that, The nucleotide sequence of the DNA barcode has a length of 120 bp and a GC base pair content of 55%.
3. A DNA barcode system for industrial strain traceability, characterized in that, The barcode system comprises: (1) the DNA barcode of claim 1; (2) a specific amplification primer pair, which comprises a forward primer and a reverse primer, the nucleotide sequence of the forward primer is shown as SEQ ID NO. 2, and the nucleotide sequence of the reverse primer is shown as SEQ ID NO.
3.
4. A method for constructing an industrial strain, characterized by, The method comprises the following steps: S1, synthesizing the DNA barcode of claim 1; S2, cloning the DNA barcode sequence into a multiple cloning site of a shuttle expression plasmid to obtain a recombinant plasmid; S3, transforming the recombinant plasmid into a host bacterium; S4, screening positive transformants to obtain an engineered strain carrying the DNA barcode sequence.
5. A method for tracing an industrial strain, characterized in that, The method comprises the following steps: S1, extracting DNA of a strain to be tested; S2, using the DNA of the strain to be tested as a template and using the forward primer and the reverse primer of claim 3 to perform PCR amplification; S3, sequencing the PCR amplification product; S4, comparing the sequencing result with the DNA barcode sequence of claim 1.
6. A recombinant plasmid, characterized in that, The recombinant plasmid comprises the DNA barcode sequence of any one of claims 1-2.
7. An engineered bacterium, characterized in that, The engineered bacterium comprises the DNA barcode sequence of any one of claims 1-2.
8. Use of the DNA barcode sequence of any one of claims 1-2, or the DNA barcode system for industrial strain tracing of claim 3, or the method for tracing an industrial strain of claim 5 in industrial strain tracing, identification, and protection of intellectual property rights of industrial strains.
9. Use according to claim 8, characterized in that, The industrial strain is selected from at least one of Corynebacterium glutamicum Corynebacterium glutamicum , Escherichia coli Escherichia coli , or Bacillus subtilis Bacillus subtilis .
